AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06205290 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bendamustine
Description: Specified dose on specified days
Study NCT06205290 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine
Description: Specified dose on specified days
Study NCT06205290 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: Specified dose on specified days
Study NCT06463535 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Omega 3
Description: SRP + OMEGA 3
Study NCT06463535 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: SRP alone
Description: Scaling and root planning
Study NCT06463535 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: SRP alone
Description: Scaling and root planning
Study NCT05754086 — intervention group
Intervention type: BEHAVIORAL
Intervention: Clear Speech
Description: This behavioral modification asks participants to speak more clearly, as if they were speaking to someone with a hearing loss.
Study NCT05754086 — intervention group
Intervention type: BEHAVIORAL
Intervention: Less Clear Speech
Description: This behavioral modification asks participants to speak less clearly, as if they were in a room with many people and they were mumbling something to the person next to them that they didn't want other people in the room to hear.
Study NCT06028061 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Adjuvant-free Quadratus lumborum block
Description: Patients are placed in the lateral decubitus position. The area where the block will be applied is disinfected with povidine iodine. A convex ultrasound probe is placed on the midaxillary line above the iliac crest. By visualizing the transverse process adjacent to the psoas major and quadratus lumborum muscles, using the in-plane technique, using a 22 gauge 80 mm peripheral block needle after negative aspiration into the anterior layer of the thoracolumbar fascia anterior to the quadratus lumborum muscle muscle, 0.5-1 ml of serum After observing hydrodissection with physiological, 20 ml of 0.25% bupivacaine is injected. The same is done to the opposite side.
Study NCT06028061 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Quadratus lumborum block III with Adjuvant
Description: The same block was applied to this group too, but a different local anesthetic mixture was used.Patients are placed in the lateral decubitus position. The area where the block will be applied is disinfected with povidine iodine. A convex ultrasound probe is placed on the midaxillary line above the iliac crest. By visualizing the transverse process adjacent to the psoas major and quadratus lumborum muscles, using the in-plane technique, using a 22 gauge 80 mm peripheral block needle after negative aspiration into the anterior layer of the thoracolumbar fascia anterior to the quadratus lumborum muscle muscle, 0.5-1 ml of serum After observing hydrodissection with physiological, 20 ml of 0.25% bupivacaine and 4mg dexamethasone is injected. The same is done to the opposite side.
Study NCT06434207 — intervention group
Intervention type: OTHER
Intervention: Collecting discarded blood samples
Description: Discarded blood samples will be collected from routine clinical labs collected before and after surgery.
Study NCT04901455 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: LAIV
Description: Standard dose of LAIV administered by a licensed health care providers.
Study NCT05388032 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Sodium Reduction Intervention
Description: The sodium reduction intervention is a dietician-led behavioral intervention consisting of two phases, first a 3-month intensive intervention phase, followed by a 9-month maintenance phase. The overall goal of the intervention is to reduce sodium intake to \<2,300 mg per day based on the most recent guideline from the National Academies of Medicine. Both phases will include individual and group behavioral modification counseling designed to facilitate a reduction in dietary sodium intake.
Study NCT05604521 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: PfSPZ Vaccine
Description: PfSPZ vaccine consists of radiation-attenuated, aseptic, purified Plasmodium falciparum (NF54) sporozoites (SPZ) cryopreserved in liquid nitrogen vapor phase (LNVP) at -150C to - 196C. PfSPZ Vaccine is composed of PfSPZ derived from the NF54 strain of Pf, which is thought to be from West Africa. PfSPZ Vaccine is diluted in phosphate buffered saline (PBS) with human serum albumin (HSA) to achieve the correct dosage and is administered by DVI.
Study NCT05604521 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: PfSPZ Challenge (7G8)
Description: PfSPZ Challenge (7G8) is similar to PfSPZ Vaccine but has not been attenuated by radiation and is therefore infectious.PfSPZ Challenge (7G8) is composed of PfSPZ derived from the 7G8 clone of Pf, which is from Brazil.
Study NCT05604521 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: PfSPZ Challenge (7G8)
Description: PfSPZ Challenge (7G8) is similar to PfSPZ Vaccine but has not been attenuated by radiation and is therefore infectious.PfSPZ Challenge (7G8) is composed of PfSPZ derived from the 7G8 clone of Pf, which is from Brazil.
Study NCT05604521 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Normal Saline
Description: 0.9% sodium chloride
Study NCT05724875 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: FLASH RT
Description: For T1 (small) lesions: 22 Gy single dose FLASH RT; For T2 (large) lesions: 5 x 6 Gy fractionated dose FLASH RT
Study NCT06184321 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Alteplase
Description: Instilled into IPC
Study NCT06184321 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Administration
Description: Instilled into IPC
Study NCT05443984 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JP-1366 20mg
Description: 1 capsule of JP-1366 20 mg, 1 tablet of esomeprazole placebo (irrespective of meals)
Study NCT05443984 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Esomeprazole 40mg
Description: 1 capsule of JP-1366 placebo, 1 tablet of esomeprazole 40 mg placebo (irrespective of meals)
Study NCT06022159 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Patients will receive the hypofractionated radiation therapy (30 Gy in 5 fractions) prior to surgery.
Description: Early post-radiotherapy toxicity will then be assessed 1 month after the end of radiotherapy.~Post-operative follow-up: post-operative complications will be followed at 3 and 6 weeks post-surgery.~A visit at 6 months post-surgery will also be carried out to evaluate post-operative complications and late adverse effects of radiotherapy.~Long-term follow-up would also be performed every 6 months from the 6-month post-surgery visit up to 3 years post-surgery (M12, M18, M24, M30 and M36).
Study NCT06022159 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Patient will undergo surgery before receive the adjuvant hypofractionated radiation therapy (40 Gy in 15 fractions).
Description: Post-operative follow-up: postoperative complications will be followed at 3 and 6 weeks post-surgery (before the start of irradiation). Early post-radiotherapy toxicity will then be assessed 1 month after the end of radiotherapy.~A 6-month post-surgery check-up will also be carried out to assess post-operative complications and acute side effects of radiotherapy.~Long-term follow-up would also be performed every 6 months from the 6-month post-surgery visit up to 3 years post-surgery (M12, M18, M24, M30 and M36).
Study NCT05520476 — intervention group
Intervention type: DEVICE
Intervention: Neuroliten MVP system
Description: The Neuroliten MVP system will be an App that gets uploaded to the patients iPhone from the App Store.
Study NCT04704089 — intervention group
Intervention type: OTHER
Intervention: spectrophotometer
Description: * Calibration of the spectrophotometer (calibration of white and green color on the provided support),~* Placing the patient or witness in the chair,~* Placement of intraoral retractors,~* Photographs of the dental arch in occlusion as well as slightly open mouth to visualize the mandibular incisors,~* If MIH is suspected, occlusal images of the occlusal surfaces of the first molars will be taken with the help of a dental mirror,~* Shooting with the spectrophotometer centered on each of the teeth of interest in the anterior sector with verification of the good quality of the shot according to the axis (validated in green on the camera),~* Backup of images with coded identification number
Study NCT04704089 — intervention group
Intervention type: OTHER
Intervention: Biological (protein analysis by western blot or mass spectrometry of matrix proteins), structural (electron microscopy) and physico-chemical analyses
Description: * Chemical analysis of enamel mineral.~* Techniques of spectrometry and spectroscopy (Raman and FTIR)~* Atomic Probe Tomography and Protein Mass Spectrometry (ICP-MS).
Study NCT05673616 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mckenzie Extension Exercises
Description: After two weeks of initial consultation, the patient will be taught to perform slouch-overcorrect on day 1 followed by flexion on day 2 in lying position and accompanied by flexion for 5 days in sitting position and finally flexion in standing will be performed.~The exercises will be repeated for 10 times and followed by extension in standing exercises.
Study NCT05618509 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: STENDO session
Description: It is a combination enveloping the lower limbs up to the abdomen. The massage system induces pressure from the ankles to the abdomen between each heartbeat. The capacity for physical exercise is potentially improved.~STENDO : 45 minutes, 2 legs and the pelvis, pression of 65mm Hg
Study NCT05724875 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional RT
Description: For T1 (small) lesions: 22 Gy single dose conventional RT; For T2 (large) lesions: 5 x 6 Gy fractionated dose conventional RT
Study NCT06538935 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: adbelimumab
Description: adbelimumab：1200mg iv d1 q3w
Study NCT06538935 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: SBRT
Description: SBRT: SBRT: 8-30Gy/1-6F（dose is determined according to the tumor diameter）; tumor thrombus dose 30Gy /5-6F;
Study NCT05618509 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: A six-minute walking distance test
Description: Before and after STENDO session, the patient has to walk 6 minutes in a flat corridor (30m long)
Study NCT05618509 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: A six-minute walking distance test
Description: Before and after STENDO session, the patient has to walk 6 minutes in a flat corridor (30m long)
Study NCT05618509 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Near Infrared Spectroscopy
Description: The goal is to measure the evolution of the oxygen consumption of the right leg during an effort on a bicycle at constant power for 5 minutes.
Study NCT05618509 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Near Infrared Spectroscopy
Description: The goal is to measure the evolution of the oxygen consumption of the right leg during an effort on a bicycle at constant power for 5 minutes.
Study NCT06441513 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Chinese traditional medicine nursing combined with case tracking management
Description: First, we set up a team for the prevention of hand foot syndrome, including 1 head nurse of the tumor chemotherapy department, 2 doctors, 16 nurses (16 nurses were divided into 4 groups, each group designated a team leader) and the researchers of this experiment. Doctors are responsible for the diagnosis of HFS and the determination of traditional Chinese medicine prescriptions, head nurses and team leaders are responsible for quality control, and nurses are responsible for the assessment, intervention and evaluation of patients.
Study NCT06441513 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Health Education
Description: elaborating the symptoms, mechanism and corresponding treatment measures of HFS for patients, reducing the fear of patients, helping them relax and adjust their mentality, and cooperating with observation.
Study NCT05323383 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness Meditation
Description: Participants in the mindfulness meditation condition will listen to a 20minute guided mindfulness meditation practice that holds the breath and body as the object of meditation.
Study NCT06538935 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: apatinib
Description: apatinib：250mg po, qd
Study NCT05323383 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Self-hypnosis
Description: Participants in self-hypnosis will listen to a 20-minute audio-guided hypnosis practice with an induction phase, followed by suggestions tailored towards shifts in affect and decentering, and then a re-alerting with post-hypnotic suggestions phase.
Study NCT06542445 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Oral CBD oil enriched with terpenes
Description: Stage I dosing, increasing titration:~days 1-2: 2.5 mg/kg BW/day; days 3-4: 5 mg/kg BW/day; day 5-7: 7.5 mg/kg BW/day; days 8-35: 10 mg/kg BW/day.~Stage II dosing, increasing titration:~days 36-37: 2.5 mg/kg BW/day; days 38-39: 5 mg/kg BW/day; day 40-42: 7.5 mg/kg BW/day; days 43-70:10 mg/kg BW/day.
Study NCT06542445 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Oral Placebo
Description: Oral placebo oil that is similar in appearance and taste to the CBD oil. Titration and dosing identical to those described for the CBD oil.
Study NCT05323383 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Attention Control
Description: Control participants will listen to a 20-minute natural history recording which was chosen as past research has found that individuals who listen to it report this to be a neutral, but relaxing passage, and it has been used as an effective control condition in previous research.
Study NCT06459557 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: cast
Description: children with displaced distal radius fractures would be managed by a cast in the emergency room
Study NCT06459557 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: surgical reduction
Description: anatomical reduction of pediatric displaced distal radius fractures under general anesthesia in the operating room
Study NCT05618509 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: STENDO placebo
Description: STENDO placebo : 45 minutes, on 2 legs and the pelvis, pression of 10 mmHg
Study NCT05982158 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Avatar therapy
Description: Seven 50-minute therapy sessions conducted by videoconferencing.
Study NCT05982158 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Cognitive behavioural therapy (CBT)
Description: Seven 50-minute therapy sessions conducted by videoconferencing.
Study NCT06488417 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Frankincense essential oil + boswellic acid supplement
Description: This supplement contains frankincense essential oil and boswellic acid as its active ingredients.
Study NCT06488417 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Frankincense essential oil supplement
Description: This supplement contains frankincense essential oil as its active ingredient.
Study NCT05087017 — intervention group
Intervention type: OTHER
Intervention: Intervention group
Description: Patients with medical condition to follow the rehabilitation program will be asked to answer questionnaires to assess their sleep quality.
Study NCT05676385 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: First concept product (containing 50 grams of carbohydrates)
Description: Fasted intake of First concept product (randomised)
Study NCT05676385 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Second concept product (containing 50 grams of carbohydrates)
Description: Fasted intake Second concept product (randomised)
Study NCT05242406 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Expiratory muscle trainig
Description: This exercise will be used to strengthen forced expiratory muscles.
Study NCT05676385 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Reference product (containing 50 grams of carbohydrates)
Description: Fasted intake of Reference product (randomised)
Study NCT03938701 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Adalimumab-800CW
Description: Intravenous administration of 4.5 mg, 15 mg or 25 mg 2 - 4 days prior to the fluorescence imaging
Study NCT03938701 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Fluorescence Imaging
Description: Fluorescence Imaging Rheumatoid Arthritis (RA):~Open-air camera - a camera that enables detection of fluorescent signals.~Fluorescence Imaging inflammatory bowel disease (IBD):~Molecular Fluorescence Endoscopy - a flexible fiber-bundle is attached to a fluorescence camera platform to enable the detection of fluorescence signals. The fluorescence fibre-probe is inserted through the standard working channel of the standard clinical endoscope. Fluorescence imaging will be performed during standard clinical colonoscopy.
Study NCT04958733 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Autologous bone grafting
Description: Autologous bone grafting is the excess bone obtained from graft preparation and the coring reamer
Study NCT05619809 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Thermogenic dietary supplement
Description: Daily ingestion of OxyShred thermogenic dietary supplement.
Study NCT05619809 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Protein supplement
Description: Daily ingestion of protein supplement.
Study NCT05619809 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Protein supplement
Description: Daily ingestion of protein supplement.
Study NCT05619809 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo supplement
Description: Daily ingestion of a placebo dietary supplement.
Study NCT05837130 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Blood sample collection and an optional cerebrospinal fluid (CSF) collection
Description: No study drug will be administered to study participants.
Study NCT05837130 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Blood sample collection
Description: No study drug will be administered to study participants.
Study NCT05193435 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pelvic floor exercises
Description: Pelvic floor exercises for types I and II muscle fibers will be performed
Study NCT05193435 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Stabilization exercises
Description: Lumbar spinal stabilization exercises will be performed
Study NCT06379139 — intervention group
Intervention type: OTHER
Intervention: •Dynamic Full-Field Optical Coherence Tomography analysis of endotracheal tube
Description: Dynamic full-field optical coherence tomography analysis of endotracheal tube sections to better apprehend strucural characterization of endotracheal tube-deposited biofilm
Study NCT05919069 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AZD2693
Description: Subcutaneous administration of AZD2693 single dose in participants with hepatic impairment
Study NCT06247579 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dietary polystyrene microplastics from disposable plastic tableware
Description: Microplastic release from the daily use of disposable plastic materials (e.g., plastic boxes) when holding hot food or drink.
Study NCT06318975 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Brief Alcohol Intervention
Description: All Airmen will receive a standard BAI during the 4th week of Technical Training, the last week of enforced abstinence. The BAI is a group-based, one-hour session which includes the following components: Interactive discussion of the positives and negatives of drinking during training and heavy vs. moderate drinking; Discussion of USAF rules on alcohol use and penalties for violations; Discussion of impact of alcohol on military readiness; effects of alcohol and hangover on performance; Review of standard drinks, blood alcohol levels and tolerance; and normative feedback on the Airmen's drinking level compared to others. We will engage in a conversation about whether they have observed concerning patterns of alcohol misuse among other USAF personnel, and how to handle this, along with harm reduction and alcohol refusal strategies.
Study NCT06318975 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Brief Alcohol Intervention
Description: All Airmen will receive a standard BAI during the 4th week of Technical Training, the last week of enforced abstinence. The BAI is a group-based, one-hour session which includes the following components: Interactive discussion of the positives and negatives of drinking during training and heavy vs. moderate drinking; Discussion of USAF rules on alcohol use and penalties for violations; Discussion of impact of alcohol on military readiness; effects of alcohol and hangover on performance; Review of standard drinks, blood alcohol levels and tolerance; and normative feedback on the Airmen's drinking level compared to others. We will engage in a conversation about whether they have observed concerning patterns of alcohol misuse among other USAF personnel, and how to handle this, along with harm reduction and alcohol refusal strategies.